ML-SYS / 2026.07NON-CLINICAL RESEARCH MATERIALSORIGIN DECLARED BY LOT

← Compound index

RM-TRS / Tissue, repair and matrix signalling

Cardiogen

Also known as: AEDR peptide ยท Ala-Glu-Asp-Arg

Preclinical evidenceEvidence grade C: Preclinical evidence

Grade describes the published research on the molecule. It is not a quality score, a safety score, or a release state.

What this is

Cardiogen is identified in the cited review as the tetrapeptide Ala-Glu-Asp-Arg, or AEDR. It must not be confused with CardioGen-82, a radiopharmaceutical generator that appears in unrelated search results.

Evidence position

Direct chemistry and preclinical records support Grade C. The cardiac evidence is essentially ex-vivo tissue culture from one research group; the in-vivo paper naming Cardiogen uses a tumor endpoint rather than a cardiovascular one.

What the record does not establish

The record does not establish a human cardiac outcome, pharmacokinetics, safety, an approved use or the identity and quality of a supplier lot.

Sources

  • 01
    Peptide regulation of gene expression: systematic reviewPubMed
    Shows
    The originating research group maps Cardiogen to the AEDR sequence and summarizes the short-peptide framework
    Does not show
    Group-authored review; the identity mapping is useful, but it is not independent functional replication
  • 02
    Cardiogen in young and aged rat myocardial tissue culturePubMed
    Shows
    Reports proliferation and p53-expression findings in ex-vivo myocardial tissue culture
    Does not show
    Cultured rat tissue only; not a living-heart disease model or human outcome
  • 03
    AEDR interaction with histones and DNA complexesPubMed
    Shows
    Direct laboratory study including the Ala-Glu-Asp-Arg sequence
    Does not show
    Plant-histone and oligonucleotide assay; does not establish cardiac activity
  • 04
    Cardiogen in an aged-rat sarcoma modelPubMed
    Shows
    An in-vivo animal study that directly names Cardiogen
    Does not show
    Cancer and tumor-vascular endpoints, not cardiac function; cannot support a cardiovascular claim
  • 05
    AEDR chemical identityPubChem
    Shows
    Registry record for H-Ala-Glu-Asp-Arg-OH, formula and molecular weight
    Does not show
    Registry identity does not authenticate a Cardiogen-labelled supplier sample

External database index

LIVE DATABASE INDEX / SEPARATE FROM CURATED EVIDENCE

Records below come directly from public scientific databases. They help find relevant material, but do not affect the evidence grade until they are matched to the molecule and added to the curated source list.

PUBMED / FOUND RECORDS

  1. Tumor-modifying effect of cardiogen peptide on M-1 sarcoma in senescent rats.Bulletin of experimental biology and medicine / 2009 SepPMID 20396706 / DOI 10.1007/s10517-010-0730-9
  2. [The effect of the amino acids and cardiogen on the development of myocard tissue culture from young and old rats].Advances in gerontology = Uspekhi gerontologii / 2009PMID 20210190
  3. [The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats].Advances in gerontology = Uspekhi gerontologii / 2006PMID 17152728
  4. [Peptidergic regulation of the expression of signal factors of fibroblast differentiation in the human prostate gland in cell aging].Advances in gerontology = Uspekhi gerontologii / 2010PMID 20586252

Related compounds